Literature DB >> 18554951

Expression and significance of hypoxemia-inducible factor-1alpha in osteosarcoma of the jaws.

Wei-liang Chen1, Hong-jie Feng, Hai-gang Li.   

Abstract

OBJECTIVE: The objective of this study was to examine the expression of hypoxia-inducible factor-1alpha (HIF-1alpha) in osteosarcoma of the jaw (OSJ) and its relationships with tumoral angiogenesis and clinicopathologic characteristics. STUDY
DESIGN: Streptavidin peroxidase immunohistochemical staining was used to detect the expression of HIF-1alpha and CD34 in paraffin-embedded samples from 25 patients. There were 14 male and 11 female patients, ages ranged from 3 to 63 years.
RESULTS: HIF-1alpha was overexpressed in OSJ. HIF-1alpha expression was correlated with tumoral microvascular density, as well as with the size, pathologic grade, and clinical stage of OSJ. Expression of HIF-1alpha was also correlated with clinicopathologic characteristics, such as primary occurrence or recurrence of the tumor, but not with metastasis.
CONCLUSION: HIF-1alpha was significantly correlated with the size, pathologic grade, clinical stage, and primary occurrence or recurrence of the OSJ. HIF-1alpha appeared to promote tumoral angiogenesis in OSJ and may be an important target in antitumoral therapy.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18554951     DOI: 10.1016/j.tripleo.2008.01.029

Source DB:  PubMed          Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol Endod        ISSN: 1079-2104


  9 in total

1.  Antiproliferative effect of Tualang honey on oral squamous cell carcinoma and osteosarcoma cell lines.

Authors:  Abdulmlik A Ghashm; Nor H Othman; Mohammed N Khattak; Noorliza M Ismail; Rajan Saini
Journal:  BMC Complement Altern Med       Date:  2010-09-14       Impact factor: 3.659

2.  Hypoxia and hypoglycaemia in Ewing's sarcoma and osteosarcoma: regulation and phenotypic effects of Hypoxia-Inducible Factor.

Authors:  Helen J Knowles; Karl-Ludwig Schaefer; Uta Dirksen; Nicholas A Athanasou
Journal:  BMC Cancer       Date:  2010-07-16       Impact factor: 4.430

3.  Prognostic role of hypoxia-inducible factor-1 alpha expression in osteosarcoma: a meta-analysis.

Authors:  Hai-Yong Ren; Yin-Hua Zhang; Heng-Yuan Li; Tao Xie; Ling-Ling Sun; Ting Zhu; Sheng-Dong Wang; Zhao-Ming Ye
Journal:  Onco Targets Ther       Date:  2016-03-14       Impact factor: 4.147

4.  Prognosis value of Hypoxia-inducible factor-1α expression in patients with bone and soft tissue sarcoma: a meta-analysis.

Authors:  Yongjiang Li; Wenbiao Zhang; Shuangjiang Li; Chongqi Tu
Journal:  Springerplus       Date:  2016-08-19

5.  Jaw osteosarcoma models in mice: first description.

Authors:  Hélios Bertin; Romain Guilho; Régis Brion; Jérôme Amiaud; Séverine Battaglia; Anne Moreau; Anne Brouchet-Gomez; Julie Longis; Benoit Piot; Dominique Heymann; Pierre Corre; Françoise Rédini
Journal:  J Transl Med       Date:  2019-02-27       Impact factor: 5.531

6.  Sphingosine Kinase-1 Is Overexpressed and Correlates with Hypoxia in Osteosarcoma: Relationship with Clinicopathological Parameters.

Authors:  Anne Gomez-Brouchet; Claire Illac; Adeline Ledoux; Pierre-Yves Fortin; Sandra de Barros; Clémentine Vabre; Fabien Despas; Sophie Peries; Christelle Casaroli; Corinne Bouvier; Sébastien Aubert; Gonzague de Pinieux; Frédérique Larousserie; Louise Galmiche; Franck Talmont; Stuart Pitson; Marie-Lise Maddelein; Olivier Cuvillier
Journal:  Cancers (Basel)       Date:  2022-01-19       Impact factor: 6.639

7.  Hypoxia-induced cytotoxic drug resistance in osteosarcoma is independent of HIF-1Alpha.

Authors:  Jennifer Adamski; Andrew Price; Caroline Dive; Guy Makin
Journal:  PLoS One       Date:  2013-06-13       Impact factor: 3.240

8.  Hypoxia promotes drug resistance in osteosarcoma cells via activating AMP-activated protein kinase (AMPK) signaling.

Authors:  Changfu Zhao; Qiao Zhang; Tao Yu; Shudong Sun; Wenjun Wang; Guangyao Liu
Journal:  J Bone Oncol       Date:  2016-01-28       Impact factor: 4.072

9.  Curcumin may serve an anticancer role in human osteosarcoma cell line U-2 OS by targeting ITPR1.

Authors:  Zhanpeng Luo; Dawei Li; Xiaobo Luo; Litao Li; Suxi Gu; Long Yu; Yuanzheng Ma
Journal:  Oncol Lett       Date:  2018-02-13       Impact factor: 2.967

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.